Organization · Venture Capital
宏科百世 (HuntBest Capital)
HuntBest Capital is a private equity and venture capital fund manager focused on biotech, chemistry, and renewable energy. It aims to facilitate cross-border investments between China and Western markets, particularly in biopharma.
Overview
What 宏科百世 (HuntBest Capital) does
What 宏科百世 (HuntBest Capital) is
HuntBest Capital is a private equity and venture capital fund manager focused on biotech, chemistry, and renewable energy. It aims to facilitate cross-border investments between China and Western markets, particularly in biopharma.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find 宏科百世 (HuntBest Capital) elsewhere
Open the official website or a supported primary organization account.
Capability profile
宏科百世 (HuntBest Capital) as a funder
Investment thesis
HuntBest Capital focuses on value-driven scientific industrialization, investing in high-quality enterprises across industry value chains, particularly in biotech and renewable energy. The firm emphasizes the development of undervalued assets in China for cross-border opportunities with the US market.
Focus narrative
HuntBest Capital is dedicated to identifying and investing in startups and growth-stage companies with significant industrialization potential. The firm operates across the industry value chain, particularly in biotech and renewable energy, and seeks to bridge opportunities between China and the United States, especially in the biopharma sector.
Value beyond capital
HuntBest Capital adds value to its portfolio companies through strategic guidance, industry expertise, and access to a network of partners in both China and the US. The firm emphasizes resource integration and operational management to enhance the growth and development of its investments.
Focus and fit
- Stages
- Seed · Series A · Growth Equity
- Sectors
- Biotech · Advanced Materials · Renewable Energy
- Regions
- Global · North America
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Juvensis: A gene-therapy drug development company targeting aging-related indications through telomere mechanisms. Leadopharma: A clinical-stage company focused on ion-channel drug R&D for chronic pain and other conditions. BioTroy: A precision-therapeutics company involved in innovative therapeutic solutions.
Common questions
What to know about 宏科百世 (HuntBest Capital)
Upseed classifies 宏科百世 (HuntBest Capital) under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.